Michael L. Levitz
2020 - Anika Therapeutics
In 2020, Michael L. Levitz earned a total compensation of $1.9M as EVP, Chief Financial Officer and Treasurer at Anika Therapeutics.
Compensation breakdown
| Bonus | $73,601 |
|---|---|
| Option Awards | $799,993 |
| Salary | $173,077 |
| Stock Awards | $799,971 |
| Other | $11,318 |
| Total | $1,857,960 |
Levitz received $800K in option awards, accounting for 43% of the total pay in 2020.
Levitz also received $73.6K in bonus, $173.1K in salary, $800K in stock awards and $11.3K in other compensation.
Rankings
In 2020, Michael L. Levitz's compensation ranked 5,854th out of 13,090 executives tracked by ExecPay. In other words, Levitz earned more than 55.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,854 out of 13,090 | 55th |
Division Manufacturing | 2,406 out of 5,620 | 57th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 307 out of 799 | 62nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 168 out of 495 | 66th |
Industry Surgical and Medical Instruments and Apparatus | 109 out of 313 | 65th |
Source: SEC filing on April 30, 2021.
Levitz's colleagues
We found six more compensation records of executives who worked with Michael L. Levitz at Anika Therapeutics in 2020.
2020
Cheryl Blanchard
Anika Therapeutics
Chief Executive Officer
2020
David Colleran
Anika Therapeutics
General Counsel
2020
Sylvia Cheung
Anika Therapeutics
Chief Financial Officer
2020
Thomas Finnerty
Anika Therapeutics
EVP, Human Resources
2020
James Loerop
Anika Therapeutics
EVP, Business Development and Strategic Planning
2020
Joseph Darling
Anika Therapeutics